India  

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak

Video Credit: HT Digital Content - Duration: 02:37s - Published
Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak

Covid: First part of phase-1 Covaxin human trial completed at PGI Rohtak

The first part of phase-1 of Covaxin human trial completed on Saturday.

The trial was conducted at Post-Graduate Institute (PGI) of Medical Sciences, Rohtak, said Dr Savita Verma, principal investigator of the vaccine trial team.

Dr Verma said that six people were administered the vaccine on Saturday under the second part of phase-1.

"First part of phase-1 of vaccine trial (Covaxin) has been completed.

50 people across India were administered the vaccine and the results were encouraging.

Six people were administered vaccine on Saturday under second part of phase-1," she said.

Human trials of Covaxin, India's first vaccine candidate against coronavirus, began at PGI Rohtak on July 17.

Three volunteers were administered Covaxin on that day.

Covid-19 vaccine candidate Covaxin, developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV), had recently got the approval for human clinical trials from the Drugs Controller General of India (DCGI).

The total number of infections crossed 13 lakh in India and so far coronavirus has claimed lives of more than 31,000 people.


You Might Like

Related news from verified sources

Covaxin: First part of phase-1 of human trials concludes at PGI Rohtak; results encouraging

Covaxin has been developed by Bharat Biotech, a pharmaceutical company based in Hyderabad.
DNA - Published


Related videos from verified sources

Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity [Video]

Watch: Health Ministry gives updates on Covid cases, vaccines & herd immunity

The health ministry in its briefing on Covid-19 situation said that over 1 million people have recovered from Covid infection in the country. Addressing the media, Secretary in the Health Ministry..

Credit: HT Digital Content     Duration: 08:50Published
First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US [Video]

First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US

First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US The experimental vaccine, developed by Moderna and the National Institute of Allergy and Infectious Diseases, began Phase 3 trials on..

Credit: Wibbitz Studio     Duration: 01:04Published
Moderna's Covid-19 vaccine enters Phase-3 trials| What phase-3 involves | Oneindia News [Video]

Moderna's Covid-19 vaccine enters Phase-3 trials| What phase-3 involves | Oneindia News

Moderna's Covid vaccine candidate entered phase 3 human trials on Monday. The trials involve 30,000 volunteers at 87 sites across the United States of America. Moderna is developing an mRNA vaccine..

Credit: Oneindia     Duration: 01:23Published